Free Trial
OTCMKTS:NVTRQ

Nuvectra (NVTRQ) Stock Price, News & Analysis

$0.02 -0.01 (-25.00%)
As of 06/2/2020

About Nuvectra Stock (OTCMKTS:NVTRQ)

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.0150
$0.0150
52-Week Range
$0.01
$4.30
Volume
382,600 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. The company offers Algovita, a spinal cord stimulation system for the treatment of chronic intractable pain of the trunk and limbs. It is also developing Virtis, a sacral neuromodulation (SNM) system for the treatment of chronic urinary retention and overactive bladder; and technologies to support other indications, including SNM for the treatment of overactive bladder and deep brain stimulation to treat Parkinson's disease. The company serves hospitals, surgery centers, and medical facilities through a direct sales force and third-party distributors in the United States and Europe. Nuvectra Corporation was founded in 2008 and is headquartered in Plano, Texas.

Receive NVTRQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuvectra and its competitors with MarketBeat's FREE daily newsletter.

NVTRQ Stock News Headlines

Imasen Electric Industrial Co Ltd (7266)
It may already be too late…
A global energy shift is underway—and lithium is at the center of it. From electric vehicles to grid storage and consumer tech, demand for lithium is surging with no signs of slowing down. But here’s the problem: supply is struggling to keep up.
See More Headlines

NVTRQ Stock Analysis - Frequently Asked Questions

Nuvectra's stock was trading at $0.0150 at the beginning of the year. Since then, NVTRQ stock has increased by 0.0% and is now trading at $0.0150.
View the best growth stocks for 2025 here
.

Nuvectra Corp (OTCMKTS:NVTRQ) announced its quarterly earnings results on Monday, October, 29th. The company reported ($0.87) earnings per share for the quarter, missing analysts' consensus estimates of ($0.86) by $0.01. The firm earned $14.22 million during the quarter, compared to analyst estimates of $12.38 million.

Shares of NVTRQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
10/29/2018
Today
5/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:NVTRQ
Previous Symbol
NASDAQ:NVTRV
Fax
N/A
Employees
197
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:NVTRQ) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners